14 Sep
by / 0 Comment

After Setbacks, a Pioneering Stem-Cell Technology Is Back in Human Trials

Biomedicine After Setbacks, a Pioneering Stem-Cell Technology Is Back in Human Trials Can cell therapy help spinal-cord injury? A long-running study hopes the answer is yes. A company that stepped in to salvage the first-ever medical use of human embryonic stem cells says it has encouraging results in patients with spinal-cord injury. Today, Asterias Biotherapeutics, […]

READ ARTICLE
standard
13 Sep
by / 0 Comment

The Struggle To Speed Study Start-up

Recent research conducted by Tufts Center for the Study of Drug Development (CSDD) has found that clinical research organizations (CROs) face an increasingly complex and competitive environment in which to administer clinical trials. Study start-up, in particular, can be a drawn-out process that, depending on the protocol, budget negotiations, and availability of patients, can last […]

READ ARTICLE
07 Sep
by / 0 Comment

FDA slams drug maker for touting unapproved leukemia treatment to docs

Talk about getting ahead of yourself. Last June, Celator Pharmaceuticals proudly displayed a large poster touting its experimental Vyxeos medication as an effective salve for treating acute myeloid leukemia. The poster was, in fact, one of countless placards featured prominently on the exhibit floor at the American Society of Clinical Oncology meeting in Chicago, a […]

READ ARTICLE
30 Aug
by / 0 Comment

As Parkinson’s patients wait, Fox Foundation and scientist feud over drug trial

  A crucial clinical trial of the most promising new treatment for Parkinson’s disease in decades might be delayed because of a feud between a key scientist and the influential Michael J. Fox Foundation. The prominent foundation — the richest nonprofit seeking to cure the crippling neurological disorder — initially wanted to collaborate on a […]

READ ARTICLE